SunTrust Robinson Humphrey analyst Edward Nash raised the price target on Dicerna Pharmaceuticals (NASDAQ: DRNA) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Dicerna Pharma (DRNA) Prices 7.68M Share Follow-On Offering at $13.02/ShSeptember 7, 2018 5:44 AM Dicerna Announces Proof of Concept for DCR-PHXC in the Treatment of Primary HyperoxaluriaSeptember 5, 2018 6:05 AM